Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 4, 2005, Pages 914-919

  Brandão, Carlos Otávio ^a   Ruocco, Heloísa Helena ^a   Dos Santos Farias, Alessandro ^a   Oliveira, Celina ^a   Hallal Longo, Dannie Eiko Maeda ^a   Mirandola, Sandra Regina ^a   Oliveira, Elaine Conceição ^a   Cendes, Fernando ^a   Damasceno, Benito Pereira ^a   Barbosa Santos, Leonilda Maria ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cerebrospinal fluid; Cytokines; Intrathecal IgG synthesis; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; OLIGOCLONAL BAND; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; REMISSION; SERUM; STATISTICAL SIGNIFICANCE;

EID: 32244438020     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2005000600002     Document Type: Article

References (30)

1. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996;85:299-302.
2. Ota K, Matsui M, Milford EL, et al. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1999;346:183-187.
3. Sharief MK, Hentges R Association between tumor necrosis factor α and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472.
4. Costa PM, Yasuda CL, Scagliusi SM, et al. Pattern of cytokines secretion by peripheral blood cells of patients with multiple sclerosis in Brazil. Mult Scler 2000;6:293-299.
5. Nicoletti F, Di Marco R, Patti F, et al. Blood levels of transforming growth factor beta 1 are elevated in both relapsing-remitting and chronic progressive multiple sclerosis patients and are further augmented by treatment with interferon beta. Clin Exp Immunol 1998;113:96-99.
6. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 1999;5:170-175.
7. Miller DH, Grossman RI, Reingold SC, Mcfarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
9. Link H, Tibbling G; Principles of albumin and IgG analyses in neurological disorders: III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977;37:397-401.
10. Keir G, Luxton RW, Thompson EJ. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann Clin Biochen 1990;27:436-443.
11. Rudick R, Cookfair D, Simonian N, et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNβ-1a) for relapsing multiple sclerosis. J Neuroimmunol 1999;93:8-14.
12. Puccioni-Sohler M, Passeri F, Oliveira C, Brandão CO, Papaiz-Alvarenga R. Multiple sclerosis in Brazil. Analysis of cerebrospinal fluid by standard methods. Arq Neuropsiquiatr 1999;57:927-931.
13. Puccioni-Sohler M, Lavrado FP, Bastos RRG, Brandão CO, Papaiz-Alvarenga R. Esclerose múltipla: correlação clínico laboratorial. Arq Neuropsiquiatr 2001;59:89-91.
14. Verjans E, Theys P, Delmotte P, Carton H. Clinical parameters and intrathecal IgG synthesis as prognostic features for multiple sclerosis. J Neurol 1983;229:155-165.
15. van Boxel-Dezaire AH, Hoff SC, van Oosten BW, et al. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol 1999;45:695-703.
16. Makhloufk K, Weiner HL, Khoury SJ. Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS. J Neuroimmunol 2001;119:145-149.
17. Heesen C, Sieverding F,. Schoser BG, Hadji B, Kunze K. Interleukin 12 is detectable in sera of patients with multiple sclerosis- association with chronic progressive disease course? Eur J Neurol 1999;6:591-596.
18. Panitch HS, Hirsch RL, Schindler J, et al. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987;37:1097-1102.
19. Hohnoki K, Inoue A, Koh CS. Elevated serum levels of IFN gamma, IL4 and TNFα unelevated serum levels of IL10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 1998;87:27-32.
20. Buntinx M, Moreels M, Vandenabeele F, et al. Cytokine- induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-γ and TNF-α on apoptosis. J Neuros Res 2004;76:834-835.
21. Rieckmann P, Albrecht M, Kitze B, et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994;44:1523-1526.
22. Choffon M, Jillard C, Gauthier G, et al. Tumor necrosis factor production as possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 1992;433:523-531.
23. Baraczka K, Nékám K, Pozsonyi T, Szuts I, Ormos G. Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol 2004;11:37-42.
24. Hartung HP, Reiners K, Archelos JJ, et al. Circulating adhesion molecules and tumor necrosis factor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-193.
25. Alves-Leon SV, Batista E, Papaiz-Alvarenga R, Quírico-Santos T. Determination of soluble ICAM-1 and TNFα R in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis. Arq Neuropsiquiatr 2001;59:18-22.
26. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;138:138-146.
27. Petereit HF, Pukrop R, Fazecas F, et al. Low interleukin- 10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. J Neurol Sci 2003;206:209-214.
28. Filion LG, Graziani-Bowering G, Matusevicius D, Freedman MS. Monocyte-derived cytokines in multiple sclerosis. Clin Exp Immunol 2003;131:324-334.
29. Huang W-X, Haung P, Link H, Hillert J. Cytokine analysis in multiple sclerosis by competitive RT PCR: a decreased expression of IL 10 and an increased expression of TNFα in chronic progression. Mult Scler 1999;5:342-348.
30. Ozenci V, Kouwenhoven M, Huang Y-M, et al. Multiple sclerosis: levels of interleukin 10-secreting blood mononuclear cells are low in untreated patients but augmented using interferon beta -1b treatment. Scand J Immunol, 1999;49:554-561.